Is vaccine confidence an unexpected victim of the COVID-19 pandemic?

•Two cohorts were surveyed in 2019 and 2022 respectively to evaluate their vaccine confidence.•Vaccine confidence has significantly declined since the onset of the COVID-19 pandemic.•All demographic groups showed a reduction in vaccine confidence post-pandemic.•Post-pandemic, middle-age participants...

Full description

Saved in:
Bibliographic Details
Published inVaccine Vol. 40; no. 50; pp. 7262 - 7269
Main Authors Siani, Alessandro, Tranter, Amy
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 28.11.2022
Elsevier Limited
The Authors. Published by Elsevier Ltd
Subjects
Online AccessGet full text

Cover

Loading…
Abstract •Two cohorts were surveyed in 2019 and 2022 respectively to evaluate their vaccine confidence.•Vaccine confidence has significantly declined since the onset of the COVID-19 pandemic.•All demographic groups showed a reduction in vaccine confidence post-pandemic.•Post-pandemic, middle-age participants were no longer the most vaccine-hesitant group. Vaccines are among the safest and most effective primary prevention measures. Thanks to the synergistic global efforts of research institutions, pharmaceutical companies and national health services, COVID-19 vaccination campaigns were successfully rolled out less than a year after the start of the pandemic. While the unprecedented speed of development and approval of COVID-19 vaccines has been applauded as a public health success story, it also spurred considerable controversy and hesitancy even amongst individuals that did not previously hold anti-vaccination stances. This study aimed to compare pre- and post-pandemic vaccine confidence trends in different demographic groups by analysing the outcomes of two online surveys run respectively in November 2019 and January 2022 involving a total of 1009 participants. Non-parametric tests highlighted a statistically significant decline in vaccine confidence in the 2022 cohort compared to the 2019 cohort, with median Vaccine Confidence Score dropping from 22 to 20 and 23.8% of participants reporting that their confidence in vaccines had declined since the onset of the pandemic. While the majority of internal trends were comparable between the two surveys with regards to gender, graduate status and religious belief, vaccine confidence patterns showed considerable alterations with regards to age and ethnicity. Middle-aged participants were considerably more hesitant than younger groups in the 2019 cohort, however this was not the case in the 2022 survey. In both surveys White participants showed significantly higher vaccine confidence than those from Black backgrounds; in the 2022 cohort, unlike the pre-pandemic group, Asian participants showed significantly lower confidence than White ones. This study suggests that paradoxically, despite the success of COVID-19 vaccination campaigns, vaccine confidence has significantly declined since the onset of the pandemic; the comparison of a pre- and post-pandemic cohort sheds light on the differential effect that the pandemic had on vaccine confidence in different demographic groups.
AbstractList Highlights•Two cohorts were surveyed in 2019 and 2022 respectively to evaluate their vaccine confidence. •Vaccine confidence has significantly declined since the onset of the COVID-19 pandemic. •All demographic groups showed a reduction in vaccine confidence post-pandemic. •Post-pandemic, middle-age participants were no longer the most vaccine-hesitant group.
Vaccines are among the safest and most effective primary prevention measures. Thanks to the synergistic global efforts of research institutions, pharmaceutical companies and national health services, COVID-19 vaccination campaigns were successfully rolled out less than a year after the start of the pandemic. While the unprecedented speed of development and approval of COVID-19 vaccines has been applauded as a public health success story, it also spurred considerable controversy and hesitancy even amongst individuals that did not previously hold anti-vaccination stances. This study aimed to compare pre- and post-pandemic vaccine confidence trends in different demographic groups by analysing the outcomes of two online surveys run respectively in November 2019 and January 2022 involving a total of 1009 participants. Non-parametric tests highlighted a statistically significant decline in vaccine confidence in the 2022 cohort compared to the 2019 cohort, with median Vaccine Confidence Score dropping from 22 to 20 and 23.8% of participants reporting that their confidence in vaccines had declined since the onset of the pandemic. While the majority of internal trends were comparable between the two surveys with regards to gender, graduate status and religious belief, vaccine confidence patterns showed considerable alterations with regards to age and ethnicity. Middle-aged participants were considerably more hesitant than younger groups in the 2019 cohort, however this was not the case in the 2022 survey. In both surveys White participants showed significantly higher vaccine confidence than those from Black backgrounds; in the 2022 cohort, unlike the pre-pandemic group, Asian participants showed significantly lower confidence than White ones. This study suggests that paradoxically, despite the success of COVID-19 vaccination campaigns, vaccine confidence has significantly declined since the onset of the pandemic; the comparison of a pre- and post-pandemic cohort sheds light on the differential effect that the pandemic had on vaccine confidence in different demographic groups.
Vaccines are among the safest and most effective primary prevention measures. Thanks to the synergistic global efforts of research institutions, pharmaceutical companies and national health services, COVID-19 vaccination campaigns were successfully rolled out less than a year after the start of the pandemic. While the unprecedented speed of development and approval of COVID-19 vaccines has been applauded as a public health success story, it also spurred considerable controversy and hesitancy even amongst individuals that did not previously hold anti-vaccination stances. This study aimed to compare pre- and post-pandemic vaccine confidence trends in different demographic groups by analysing the outcomes of two online surveys run respectively in November 2019 and January 2022 involving a total of 1009 participants. Non-parametric tests highlighted a statistically significant decline in vaccine confidence in the 2022 cohort compared to the 2019 cohort, with median Vaccine Confidence Score dropping from 22 to 20 and 23.8% of participants reporting that their confidence in vaccines had declined since the onset of the pandemic. While the majority of internal trends were comparable between the two surveys with regards to gender, graduate status and religious belief, vaccine confidence patterns showed considerable alterations with regards to age and ethnicity. Middle-aged participants were considerably more hesitant than younger groups in the 2019 cohort, however this was not the case in the 2022 survey. In both surveys White participants showed significantly higher vaccine confidence than those from Black backgrounds; in the 2022 cohort, unlike the pre-pandemic group, Asian participants showed significantly lower confidence than White ones. This study suggests that paradoxically, despite the success of COVID-19 vaccination campaigns, vaccine confidence has significantly declined since the onset of the pandemic; the comparison of a pre- and post-pandemic cohort sheds light on the differential effect that the pandemic had on vaccine confidence in different demographic groups.Vaccines are among the safest and most effective primary prevention measures. Thanks to the synergistic global efforts of research institutions, pharmaceutical companies and national health services, COVID-19 vaccination campaigns were successfully rolled out less than a year after the start of the pandemic. While the unprecedented speed of development and approval of COVID-19 vaccines has been applauded as a public health success story, it also spurred considerable controversy and hesitancy even amongst individuals that did not previously hold anti-vaccination stances. This study aimed to compare pre- and post-pandemic vaccine confidence trends in different demographic groups by analysing the outcomes of two online surveys run respectively in November 2019 and January 2022 involving a total of 1009 participants. Non-parametric tests highlighted a statistically significant decline in vaccine confidence in the 2022 cohort compared to the 2019 cohort, with median Vaccine Confidence Score dropping from 22 to 20 and 23.8% of participants reporting that their confidence in vaccines had declined since the onset of the pandemic. While the majority of internal trends were comparable between the two surveys with regards to gender, graduate status and religious belief, vaccine confidence patterns showed considerable alterations with regards to age and ethnicity. Middle-aged participants were considerably more hesitant than younger groups in the 2019 cohort, however this was not the case in the 2022 survey. In both surveys White participants showed significantly higher vaccine confidence than those from Black backgrounds; in the 2022 cohort, unlike the pre-pandemic group, Asian participants showed significantly lower confidence than White ones. This study suggests that paradoxically, despite the success of COVID-19 vaccination campaigns, vaccine confidence has significantly declined since the onset of the pandemic; the comparison of a pre- and post-pandemic cohort sheds light on the differential effect that the pandemic had on vaccine confidence in different demographic groups.
•Two cohorts were surveyed in 2019 and 2022 respectively to evaluate their vaccine confidence.•Vaccine confidence has significantly declined since the onset of the COVID-19 pandemic.•All demographic groups showed a reduction in vaccine confidence post-pandemic.•Post-pandemic, middle-age participants were no longer the most vaccine-hesitant group. Vaccines are among the safest and most effective primary prevention measures. Thanks to the synergistic global efforts of research institutions, pharmaceutical companies and national health services, COVID-19 vaccination campaigns were successfully rolled out less than a year after the start of the pandemic. While the unprecedented speed of development and approval of COVID-19 vaccines has been applauded as a public health success story, it also spurred considerable controversy and hesitancy even amongst individuals that did not previously hold anti-vaccination stances. This study aimed to compare pre- and post-pandemic vaccine confidence trends in different demographic groups by analysing the outcomes of two online surveys run respectively in November 2019 and January 2022 involving a total of 1009 participants. Non-parametric tests highlighted a statistically significant decline in vaccine confidence in the 2022 cohort compared to the 2019 cohort, with median Vaccine Confidence Score dropping from 22 to 20 and 23.8% of participants reporting that their confidence in vaccines had declined since the onset of the pandemic. While the majority of internal trends were comparable between the two surveys with regards to gender, graduate status and religious belief, vaccine confidence patterns showed considerable alterations with regards to age and ethnicity. Middle-aged participants were considerably more hesitant than younger groups in the 2019 cohort, however this was not the case in the 2022 survey. In both surveys White participants showed significantly higher vaccine confidence than those from Black backgrounds; in the 2022 cohort, unlike the pre-pandemic group, Asian participants showed significantly lower confidence than White ones. This study suggests that paradoxically, despite the success of COVID-19 vaccination campaigns, vaccine confidence has significantly declined since the onset of the pandemic; the comparison of a pre- and post-pandemic cohort sheds light on the differential effect that the pandemic had on vaccine confidence in different demographic groups.
Vaccines are among the safest and most effective primary prevention measures. Thanks to the synergistic global efforts of research institutions, pharmaceutical companies and national health services, COVID-19 vaccination campaigns were successfully rolled out less than a year after the start of the pandemic. While the unprecedented speed of development and approval of COVID-19 vaccines has been applauded as a public health success story, it also spurred considerable controversy and hesitancy even amongst individuals that did not previously hold anti-vaccination stances. This study aimed to compare pre- and post-pandemic vaccine confidence trends in different demographic groups by analysing the outcomes of two online surveys run respectively in November 2019 and January 2022 involving a total of 1009 participants. Non-parametric tests highlighted a statistically significant decline in vaccine confidence in the 2022 cohort compared to the 2019 cohort, with median Vaccine Confidence Score dropping from 22 to 20 and 23.8% of participants reporting that their confidence in vaccines had declined since the onset of the pandemic. While the majority of internal trends were comparable between the two surveys with regards to gender, graduate status and religious belief, vaccine confidence patterns showed considerable alterations with regards to age and ethnicity. Middle-aged participants were considerably more hesitant than younger groups in the 2019 cohort, however this was not the case in the 2022 survey. In both surveys White participants showed significantly higher vaccine confidence than those from Black backgrounds; in the 2022 cohort, unlike the pre-pandemic group, Asian participants showed significantly lower confidence than White ones. This study suggests that paradoxically, despite the success of COVID-19 vaccination campaigns, vaccine confidence has significantly declined since the onset of the pandemic; the comparison of a pre- and post-pandemic cohort sheds light on the differential effect that the pandemic had on vaccine confidence in different demographic groups.
Author Tranter, Amy
Siani, Alessandro
Author_xml – sequence: 1
  givenname: Alessandro
  orcidid: 0000-0002-0652-2489
  surname: Siani
  fullname: Siani, Alessandro
  email: alessandro.siani@port.ac.uk
– sequence: 2
  givenname: Amy
  surname: Tranter
  fullname: Tranter, Amy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36333226$$D View this record in MEDLINE/PubMed
BookMark eNqNkt1rE0EUxQep2LT6JygLvviy6XzvLmKLpFoDhT74gW_D7J27duJmJu5sgv3v3SUxaEDi08Cd3z0czrln5CTEgIQ8Z3TKKNMXi-nGAviAU045H2ZTqtkjMmFlIXKuWHlCJpRrmUtGv56Ss5QWlFIlWPWEnAothOBcT8j1PGU7oQxiaLzDAJjZkK0D_lwh9OiyjYfeL7PYZP09ZrO7L_PrnFXZygaHSw9XT8njxrYJn-3ec_L5_btPsw_57d3NfPb2Ngeliz5XTNV12ZSDDXB143QhQVbSWaxsIXQNTaEAlKVN1Ths6lKA0JzWsnRMo0RxTi63uqt1vUQHGPrOtmbV-aXtHky03vz9E_y9-RY3ptKslFINAq92Al38scbUm6VPgG1rA8Z1MoJLTiWTpT6K8kJwJQWjI_ryAF3EdReGJEaqkLKkqhyoF3-a37v-3cUAqC0AXUypw2aPMGrGzs3C7KoyY-fjeOh82Ht9sAe-t72PYwa-Pbp9td3GobiNx84k8OMNON8N7RsX_VGFywMFaH3wYNvv-IBpnwUziRtqPo5XOR4l55QJUYzJvPm3wH8Y-AVCB_Nl
CitedBy_id crossref_primary_10_1186_s12889_024_18489_8
crossref_primary_10_1080_22423982_2023_2295042
crossref_primary_10_3390_covid5040045
crossref_primary_10_1016_j_vaccine_2024_126236
crossref_primary_10_1016_j_vaccine_2023_12_080
crossref_primary_10_2196_56559
crossref_primary_10_3389_fpubh_2023_1148029
crossref_primary_10_1186_s12913_023_10141_2
crossref_primary_10_1007_s44202_024_00288_2
crossref_primary_10_3390_vaccines12050458
crossref_primary_10_1038_s41404_022_1824_6
crossref_primary_10_1080_21645515_2023_2225388
crossref_primary_10_1164_rccm_202410_1883VP
crossref_primary_10_1016_j_vaccine_2024_06_037
crossref_primary_10_1080_21645515_2025_2457198
crossref_primary_10_1111_trf_18051
crossref_primary_10_1080_21645515_2023_2265640
crossref_primary_10_1002_ase_2417
crossref_primary_10_7759_cureus_56943
crossref_primary_10_1093_jtm_taad056
crossref_primary_10_1097_IPC_0000000000001352
crossref_primary_10_1007_s10461_025_04622_0
crossref_primary_10_1016_j_vaccine_2023_03_030
crossref_primary_10_51819_jaltc_2023_1374608
crossref_primary_10_1080_21645515_2023_2237374
crossref_primary_10_1515_ohe_2023_0016
crossref_primary_10_37016_mr_2020_148
crossref_primary_10_1111_jrh_12839
crossref_primary_10_12968_bjhc_2023_0105
crossref_primary_10_1016_j_vaccine_2024_06_047
crossref_primary_10_1186_s12889_024_20953_4
Cites_doi 10.1016/j.vaccine.2015.04.036
10.3389/fpubh.2022.878159
10.1016/j.vaccine.2020.04.068
10.7591/9781501735639
10.1016/j.jiph.2022.06.007
10.1111/1467-9566.13474
10.1016/j.vaccine.2014.09.039
10.1038/d41586-020-03626-1
10.1016/j.ypmed.2019.02.011
10.4161/hv.26224
10.1016/S0140-6736(21)00306-8
10.15585/mmwr.mm7105a3
10.1001/jama.2020.15725
10.3389/fpubh.2022.824560
10.1016/j.eclinm.2020.100387
10.1016/S0140-6736(21)02178-4
10.3389/fpubh.2021.752323
10.1371/journal.pone.0258462
10.1007/s11845-021-02640-0
10.1016/j.puhe.2021.02.025
10.1016/B978-1-4160-3611-1.50005-2
10.1371/journal.pone.0250123
10.1016/j.immuni.2021.07.017
10.1016/j.vaccine.2017.12.043
ContentType Journal Article
Copyright 2022 The Authors
The Authors
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.
2022. The Authors
2022 The Authors. Published by Elsevier Ltd. 2022
Copyright_xml – notice: 2022 The Authors
– notice: The Authors
– notice: Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.
– notice: 2022. The Authors
– notice: 2022 The Authors. Published by Elsevier Ltd. 2022
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7RV
7T2
7T5
7U9
7X7
7XB
88C
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9-
K9.
KB0
LK8
M0R
M0S
M0T
M1P
M2O
M7N
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
7S9
L.6
5PM
DOI 10.1016/j.vaccine.2022.10.061
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Nursing & Allied Health Database
Health and Safety Science Abstracts (Full archive)
Immunology Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Healthcare Administration Database (Alumni)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
AIDS and Cancer Research Abstracts
SciTech Premium Collection
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
Consumer Health Database
Health & Medical Collection (Alumni)
Healthcare Administration Database
Proquest Medical Database
Research Library
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Health Management (Alumni Edition)
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Research Library
Health & Safety Science Abstracts
ProQuest Public Health
ProQuest Central Basic
ProQuest Health Management
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
ProQuest Medical Library
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList

MEDLINE - Academic


MEDLINE
Research Library Prep
AGRICOLA
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Veterinary Medicine
Biology
Pharmacy, Therapeutics, & Pharmacology
Public Health
EISSN 1873-2518
EndPage 7269
ExternalDocumentID PMC9618445
36333226
10_1016_j_vaccine_2022_10_061
S0264410X22013378
1_s2_0_S0264410X22013378
Genre Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
4.4
457
4G.
53G
5RE
5VS
7-5
71M
7RV
7X7
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8P~
9JM
AAAJQ
AABNK
AAEDT
AAEDW
AAHBH
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AARKO
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABFRF
ABJNI
ABKYH
ABMAC
ABMZM
ABRWV
ABUWG
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACPRK
ACRLP
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEUYN
AEVXI
AEXOQ
AFKRA
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGCQF
AGEKW
AGGSO
AGUBO
AGYEJ
AHMBA
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
AQUVI
AXJTR
AZQEC
BBNVY
BENPR
BHPHI
BKEYQ
BKNYI
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
CCPQU
CJTIS
CNWQP
CS3
DWQXO
EBS
EFJIC
EFKBS
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
FYUFA
G-Q
GBLVA
GNUQQ
GUQSH
HCIFZ
HMCUK
IHE
J1W
K9-
KOM
L7B
LK8
LUGTX
LW9
M0R
M0T
M1P
M29
M2O
M41
M7P
MO0
N9A
NAPCQ
O-L
O9-
O9~
OAUVE
OK0
OZT
P-8
P-9
P2P
PC.
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PUEGO
Q38
ROL
RPZ
SAB
SCC
SDF
SDG
SDP
SES
SNL
SPCBC
SSH
SSI
SSZ
T5K
UKHRP
UV1
WH7
WOW
Z5R
~G-
.GJ
29Q
3V.
AACTN
AAQXK
ABWVN
ABXDB
ACRPL
ADMUD
ADNMO
ADVLN
AFCTW
AFJKZ
AFKWA
AGHFR
AHHHB
AJOXV
ALIPV
AMFUW
ASPBG
AVWKF
AZFZN
EJD
FEDTE
FGOYB
G-2
HEJ
HLV
HMG
HMK
HMO
HVGLF
HX~
HZ~
R2-
RIG
SAE
SEW
SIN
SVS
WUQ
XPP
ZGI
ZXP
6I.
AAFTH
AAIAV
ABLVK
ABYKQ
AESVU
EFLBG
LCYCR
QYZTP
AAYXX
ACMHX
ADSLC
AGQPQ
AGRNS
AGWPP
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T2
7T5
7U9
7XB
8FK
C1K
H94
K9.
M7N
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
7S9
L.6
5PM
ID FETCH-LOGICAL-c567t-515bb8f8005cdbfd674c494dae9a736bcf75cc5a0f9fdefb83c3620b48d16e4e3
IEDL.DBID 7X7
ISSN 0264-410X
1873-2518
IngestDate Thu Aug 21 18:38:35 EDT 2025
Fri Aug 22 20:26:28 EDT 2025
Fri Jul 11 00:36:00 EDT 2025
Wed Aug 13 07:22:42 EDT 2025
Wed Feb 19 02:26:10 EST 2025
Tue Jul 01 01:07:10 EDT 2025
Thu Apr 24 22:58:28 EDT 2025
Fri Feb 23 02:38:54 EST 2024
Tue Feb 25 20:07:26 EST 2025
Tue Aug 26 16:34:38 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 50
Keywords COVID-19
Demographics
Survey
Vaccine hesitancy
Vaccine confidence
Language English
License This is an open access article under the CC BY license.
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c567t-515bb8f8005cdbfd674c494dae9a736bcf75cc5a0f9fdefb83c3620b48d16e4e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-0652-2489
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0264410X22013378
PMID 36333226
PQID 2737448058
PQPubID 105530
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9618445
proquest_miscellaneous_3242041486
proquest_miscellaneous_2732543106
proquest_journals_2737448058
pubmed_primary_36333226
crossref_primary_10_1016_j_vaccine_2022_10_061
crossref_citationtrail_10_1016_j_vaccine_2022_10_061
elsevier_sciencedirect_doi_10_1016_j_vaccine_2022_10_061
elsevier_clinicalkeyesjournals_1_s2_0_S0264410X22013378
elsevier_clinicalkey_doi_10_1016_j_vaccine_2022_10_061
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-11-28
PublicationDateYYYYMMDD 2022-11-28
PublicationDate_xml – month: 11
  year: 2022
  text: 2022-11-28
  day: 28
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
– name: Kidlington
PublicationTitle Vaccine
PublicationTitleAlternate Vaccine
PublicationYear 2022
Publisher Elsevier Ltd
Elsevier Limited
The Authors. Published by Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
– name: Elsevier Limited
– name: The Authors. Published by Elsevier Ltd
References Ball (b0075) 2021; 589
Lee, Sibley (b0170) 2020; 23
World Health Organization. Report of the SAGE Working Group on Vaccine Hesitancy; 2014.
Patel, Berenson (b0175) 2013; 9
Bok K, Sitar S, Graham BS, Mascola JR. Accelerated COVID-19 vaccine development: milestones, lessons, and prospects. 8 ed. United States: Elsevier Science B.V., Amsterdam; 2021. p. 1636–51.
Woolf, McManus, Martin, Nellums, Guyatt, Melbourne (b0185) 2021; 9
MacDonald (b0055) 2015; 33
Fadi, Mohamad-Hani, Khalid, Shuliweeh, Ali, Abdulkarim (b0120) 2022; 15
Siani, Driscoll, Hurst, Coker, Grantham, Bunet (b0105) 2021
Shah, Marks, Hahn (b0090) 2020; 324
Razai, Osama, McKechnie, Majeed (b0190) 2021; 372
World Health Organization. Ten threats to global health in 2019; 2019.
Wouters, Shadlen, Salcher-Konrad, Pollard, Larson, Teerawattananon (b0095) 2021; 397
Troiano, Nardi (b0080) 2021; 194
Dube E, Gagnon D, Nickels E, Jeram S, Schuster M. Mapping vaccine hesitancy-Country-specific characteristics of a global phenomenon. Great Britain: Elsevier Science B.V., Amsterdam.; 2014. p. 6649.
Siani (b0050) 2019; 121
McNaghten AD, Brewer NT, Mei-Chuan H, Peng-Jun L, Daskalakis D, Abad N, et al. COVID-19 Vaccination Coverage and Vaccine Confidence by Sexual Orientation and Gender Identity -- United States, August 29-October 30, 2021. MMWR: Morbidity & Mortality Weekly Report. 2022;71:171–6.
Gerretsen, Kim, Caravaggio, Quilty, Sanches, Wells (b0065) 2021; 16
Morales, Beltran, Morales (b0155) 2022
Falcaro, Castañon, Ndlela, Checchi, Soldan, Lopez-Bernal (b0020) 2021; 398
Wakefield, Murch, Anthony, Linnell, Casson, Malik (b0025) 1998
Siani A. Vaccine hesitancy and refusal: history, causes, mitigation strategies. In: Rezaei N, editor. Integrated Science of Global Epidemics: Springer; 2022. ISBN: 978-3-031-17777-4, Series E-ISSN: 2662-947X.
Shapiro GK, Amsel R, Knauper B, Perez S, Rosberger Z, Tatar O, et al. The vaccine hesitancy scale: Psychometric properties and validation. Vaccine 2018;36:660-7-7. doi: 10.1016/j.vaccine.2017.12.043.
Our World In Data. Coronavirus (COVID-19) Vaccinations; 2022.
Fridman, Gershon, Gneezy (b0110) 2021; 16
Kibongani Volet, Scavone, Catalán-Matamoros, Capuano (b0160) 2022; 10
Hausman BL. Anti/Vax: reframing the vaccination controversy: Ilr Press; 2019.
Temsah, Aljamaan, Alenezi, Alhasan, Alrabiaah, Assiri (b0115) 2022; 10
Spetz, Lundberg, Nwaru, Li, Santosa, Leach (b0125) 2022; 15
Zintel, Flock, Arbogast, Forster, von Wagner, Sieverding (b0135) 2022
Temsah M-H, Alhuzaimi AN, Aljamaan F, Bahkali F, Al-Eyadhy A, Alrabiaah A, et al. Parental attitudes and hesitancy about COVID-19 versus routine childhood vaccinations: a national survey. Front Public Health 2021:1513.
Siani, Carter, Moulton (b0180) 2022; 63
Sreevatsava, Burman, Wahdan, Safdar, O'Leary, Amjad (b0040) 2020; 38
World Health Organization. Vaccines and immunization; 2022.
Arvanitis, Opsasnick, O'Conor, Curtis, Vuyyuru, Yoshino Benavente (b0130) 2021; 24
Plotkin SL, Plotkin SA. A short history of vaccination. Vaccines 2004;5:1–16.
Barry, Temsah, Aljamaan, Saddik, Al-Eyadhy, Alenezi (b0140) 2021
Nazlı, Yığman, Sevindik, Deniz (b0085) 2022; 191
Morales (10.1016/j.vaccine.2022.10.061_b0155) 2022
Falcaro (10.1016/j.vaccine.2022.10.061_b0020) 2021; 398
Arvanitis (10.1016/j.vaccine.2022.10.061_b0130) 2021; 24
Siani (10.1016/j.vaccine.2022.10.061_b0180) 2022; 63
Shah (10.1016/j.vaccine.2022.10.061_b0090) 2020; 324
Troiano (10.1016/j.vaccine.2022.10.061_b0080) 2021; 194
MacDonald (10.1016/j.vaccine.2022.10.061_b0055) 2015; 33
Patel (10.1016/j.vaccine.2022.10.061_b0175) 2013; 9
10.1016/j.vaccine.2022.10.061_b0060
Siani (10.1016/j.vaccine.2022.10.061_b0105) 2021
Ball (10.1016/j.vaccine.2022.10.061_b0075) 2021; 589
Fridman (10.1016/j.vaccine.2022.10.061_b0110) 2021; 16
10.1016/j.vaccine.2022.10.061_b0165
10.1016/j.vaccine.2022.10.061_b0045
10.1016/j.vaccine.2022.10.061_b0100
Sreevatsava (10.1016/j.vaccine.2022.10.061_b0040) 2020; 38
Wouters (10.1016/j.vaccine.2022.10.061_b0095) 2021; 397
Kibongani Volet (10.1016/j.vaccine.2022.10.061_b0160) 2022; 10
10.1016/j.vaccine.2022.10.061_b0005
10.1016/j.vaccine.2022.10.061_b0145
Fadi (10.1016/j.vaccine.2022.10.061_b0120) 2022; 15
Nazlı (10.1016/j.vaccine.2022.10.061_b0085) 2022; 191
Razai (10.1016/j.vaccine.2022.10.061_b0190) 2021; 372
Wakefield (10.1016/j.vaccine.2022.10.061_b0025) 1998
Gerretsen (10.1016/j.vaccine.2022.10.061_b0065) 2021; 16
Temsah (10.1016/j.vaccine.2022.10.061_b0115) 2022; 10
Zintel (10.1016/j.vaccine.2022.10.061_b0135) 2022
Woolf (10.1016/j.vaccine.2022.10.061_b0185) 2021; 9
Spetz (10.1016/j.vaccine.2022.10.061_b0125) 2022; 15
10.1016/j.vaccine.2022.10.061_b0070
Barry (10.1016/j.vaccine.2022.10.061_b0140) 2021
Lee (10.1016/j.vaccine.2022.10.061_b0170) 2020; 23
Siani (10.1016/j.vaccine.2022.10.061_b0050) 2019; 121
10.1016/j.vaccine.2022.10.061_b0150
10.1016/j.vaccine.2022.10.061_b0030
10.1016/j.vaccine.2022.10.061_b0010
10.1016/j.vaccine.2022.10.061_b0015
10.1016/j.vaccine.2022.10.061_b0035
References_xml – reference: Bok K, Sitar S, Graham BS, Mascola JR. Accelerated COVID-19 vaccine development: milestones, lessons, and prospects. 8 ed. United States: Elsevier Science B.V., Amsterdam; 2021. p. 1636–51.
– year: 1998
  ident: b0025
  article-title: RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children
– reference: Our World In Data. Coronavirus (COVID-19) Vaccinations; 2022.
– volume: 63
  year: 2022
  ident: b0180
  article-title: Political views and science literacy as indicators of vaccine confidence and COVID-19 concern
  publication-title: J Prevent Med Hygiene
– volume: 15
  start-page: 773
  year: 2022
  end-page: 780
  ident: b0120
  article-title: SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes
  publication-title: J Infect Public Health
– volume: 9
  year: 2021
  ident: b0185
  article-title: Ethnic differences in SARS-CoV-2 vaccine hesitancy in United Kingdom healthcare workers: Results from the UK-REACH prospective nationwide cohort study
  publication-title: Lancet Reg Health Europe
– volume: 589
  start-page: 16
  year: 2021
  end-page: 18
  ident: b0075
  article-title: The lightning-fast quest for COVID vaccines - and what it means for other diseases
  publication-title: Nature
– reference: Shapiro GK, Amsel R, Knauper B, Perez S, Rosberger Z, Tatar O, et al. The vaccine hesitancy scale: Psychometric properties and validation. Vaccine 2018;36:660-7-7. doi: 10.1016/j.vaccine.2017.12.043.
– volume: 324
  start-page: 931
  year: 2020
  end-page: 932
  ident: b0090
  article-title: Unwavering Regulatory Safeguards for COVID-19 Vaccines
  publication-title: JAMA
– reference: World Health Organization. Ten threats to global health in 2019; 2019.
– volume: 121
  start-page: 99
  year: 2019
  end-page: 104
  ident: b0050
  article-title: Measles outbreaks in Italy: A paradigm of the re-emergence of vaccine-preventable diseases in developed countries
  publication-title: Prev Med
– reference: Hausman BL. Anti/Vax: reframing the vaccination controversy: Ilr Press; 2019.
– reference: Siani A. Vaccine hesitancy and refusal: history, causes, mitigation strategies. In: Rezaei N, editor. Integrated Science of Global Epidemics: Springer; 2022. ISBN: 978-3-031-17777-4, Series E-ISSN: 2662-947X.
– volume: 191
  start-page: 71
  year: 2022
  end-page: 80
  ident: b0085
  article-title: Psychological factors affecting COVID-19 vaccine hesitancy
  publication-title: Ir J Med Sci
– volume: 10
  year: 2022
  ident: b0115
  article-title: SARS-COV-2 omicron variant: exploring healthcare workers' awareness and perception of vaccine effectiveness: a national survey during the first week of WHO variant alert
  publication-title: Front Public Health
– volume: 23
  year: 2020
  ident: b0170
  article-title: Attitudes toward vaccinations are becoming more polarized in New Zealand: Findings from a longitudinal survey
  publication-title: EClinicalMedicine
– reference: World Health Organization. Vaccines and immunization; 2022.
– volume: 16
  start-page: e0258462
  year: 2021
  ident: b0065
  article-title: Individual determinants of COVID-19 vaccine hesitancy
  publication-title: PLoS ONE
– start-page: 5762
  year: 2021
  end-page: 5768
  ident: b0140
  article-title: COVID-19 vaccine uptake among healthcare workers in the fourth country to authorize BNT162b2 during the first month of rollout
– year: 2022
  ident: b0155
  article-title: Gender, socioeconomic status, and COVID-19 vaccine hesitancy in the US: An intersectionality approach
  publication-title: Sociol Health Illn
– volume: 24
  year: 2021
  ident: b0130
  article-title: Factors associated with COVID-19 vaccine trust and hesitancy among adults with chronic conditions
  publication-title: Prevent Med Rep
– reference: McNaghten AD, Brewer NT, Mei-Chuan H, Peng-Jun L, Daskalakis D, Abad N, et al. COVID-19 Vaccination Coverage and Vaccine Confidence by Sexual Orientation and Gender Identity -- United States, August 29-October 30, 2021. MMWR: Morbidity & Mortality Weekly Report. 2022;71:171–6.
– volume: 10
  year: 2022
  ident: b0160
  article-title: Vaccine Hesitancy Among Religious Groups: Reasons Underlying This Phenomenon and Communication Strategies to Rebuild Trust
  publication-title: Front Public Health
– start-page: 1
  year: 2022
  end-page: 25
  ident: b0135
  article-title: Gender differences in the intention to get vaccinated against COVID-19: a systematic review and meta-analysis
  publication-title: Zeitschrift fur Gesundheitswissenschaften = J Public Health
– volume: 372
  year: 2021
  ident: b0190
  article-title: Covid-19 vaccine hesitancy among ethnic minority groups
  publication-title: BMJ (Clinical Research ed)
– volume: 15
  year: 2022
  ident: b0125
  article-title: The social patterning of Covid-19 vaccine uptake in older adults: A register-based cross-sectional study in Sweden
  publication-title: Lancet Reg Health Europe
– volume: 9
  start-page: 2649
  year: 2013
  end-page: 2653
  ident: b0175
  article-title: Sources of HPV vaccine hesitancy in parents
  publication-title: Human Vaccines Immunother
– volume: 38
  start-page: 4399
  year: 2020
  end-page: 4404
  ident: b0040
  article-title: Routine immunization coverage in Pakistan: a survey of children under 1 year of age in community-based vaccination areas
  publication-title: Vaccine
– volume: 194
  start-page: 245
  year: 2021
  end-page: 251
  ident: b0080
  article-title: Vaccine hesitancy in the era of COVID-19
  publication-title: Public Health
– reference: Temsah M-H, Alhuzaimi AN, Aljamaan F, Bahkali F, Al-Eyadhy A, Alrabiaah A, et al. Parental attitudes and hesitancy about COVID-19 versus routine childhood vaccinations: a national survey. Front Public Health 2021:1513.
– reference: Plotkin SL, Plotkin SA. A short history of vaccination. Vaccines 2004;5:1–16.
– volume: 398
  start-page: 2084
  year: 2021
  end-page: 2092
  ident: b0020
  article-title: The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study
  publication-title: Lancet
– start-page: 1
  year: 2021
  end-page: 9
  ident: b0105
  article-title: Investigating the determinants of vaccine hesitancy within undergraduate students' social sphere
  publication-title: J Public Health
– reference: Dube E, Gagnon D, Nickels E, Jeram S, Schuster M. Mapping vaccine hesitancy-Country-specific characteristics of a global phenomenon. Great Britain: Elsevier Science B.V., Amsterdam.; 2014. p. 6649.
– volume: 33
  start-page: 4161
  year: 2015
  end-page: 4164
  ident: b0055
  article-title: Vaccine hesitancy: Definition, scope and determinants
  publication-title: Vaccine
– volume: 397
  start-page: 1023
  year: 2021
  end-page: 1034
  ident: b0095
  article-title: Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment
  publication-title: Lancet
– reference: World Health Organization. Report of the SAGE Working Group on Vaccine Hesitancy; 2014.
– volume: 16
  year: 2021
  ident: b0110
  article-title: COVID-19 and vaccine hesitancy: A longitudinal study
  publication-title: PLoS ONE
– volume: 33
  start-page: 4161
  year: 2015
  ident: 10.1016/j.vaccine.2022.10.061_b0055
  article-title: Vaccine hesitancy: Definition, scope and determinants
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2015.04.036
– year: 1998
  ident: 10.1016/j.vaccine.2022.10.061_b0025
– volume: 10
  year: 2022
  ident: 10.1016/j.vaccine.2022.10.061_b0115
  article-title: SARS-COV-2 omicron variant: exploring healthcare workers' awareness and perception of vaccine effectiveness: a national survey during the first week of WHO variant alert
  publication-title: Front Public Health
  doi: 10.3389/fpubh.2022.878159
– volume: 38
  start-page: 4399
  year: 2020
  ident: 10.1016/j.vaccine.2022.10.061_b0040
  article-title: Routine immunization coverage in Pakistan: a survey of children under 1 year of age in community-based vaccination areas
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2020.04.068
– volume: 372
  year: 2021
  ident: 10.1016/j.vaccine.2022.10.061_b0190
  article-title: Covid-19 vaccine hesitancy among ethnic minority groups
  publication-title: BMJ (Clinical Research ed)
– ident: 10.1016/j.vaccine.2022.10.061_b0060
– ident: 10.1016/j.vaccine.2022.10.061_b0030
  doi: 10.7591/9781501735639
– volume: 15
  start-page: 773
  year: 2022
  ident: 10.1016/j.vaccine.2022.10.061_b0120
  article-title: SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes
  publication-title: J Infect Public Health
  doi: 10.1016/j.jiph.2022.06.007
– volume: 15
  year: 2022
  ident: 10.1016/j.vaccine.2022.10.061_b0125
  article-title: The social patterning of Covid-19 vaccine uptake in older adults: A register-based cross-sectional study in Sweden
  publication-title: Lancet Reg Health Europe
– year: 2022
  ident: 10.1016/j.vaccine.2022.10.061_b0155
  article-title: Gender, socioeconomic status, and COVID-19 vaccine hesitancy in the US: An intersectionality approach
  publication-title: Sociol Health Illn
  doi: 10.1111/1467-9566.13474
– ident: 10.1016/j.vaccine.2022.10.061_b0165
  doi: 10.1016/j.vaccine.2014.09.039
– start-page: 5762
  year: 2021
  ident: 10.1016/j.vaccine.2022.10.061_b0140
– volume: 63
  year: 2022
  ident: 10.1016/j.vaccine.2022.10.061_b0180
  article-title: Political views and science literacy as indicators of vaccine confidence and COVID-19 concern
  publication-title: J Prevent Med Hygiene
– volume: 589
  start-page: 16
  year: 2021
  ident: 10.1016/j.vaccine.2022.10.061_b0075
  article-title: The lightning-fast quest for COVID vaccines - and what it means for other diseases
  publication-title: Nature
  doi: 10.1038/d41586-020-03626-1
– volume: 121
  start-page: 99
  year: 2019
  ident: 10.1016/j.vaccine.2022.10.061_b0050
  article-title: Measles outbreaks in Italy: A paradigm of the re-emergence of vaccine-preventable diseases in developed countries
  publication-title: Prev Med
  doi: 10.1016/j.ypmed.2019.02.011
– start-page: 1
  year: 2021
  ident: 10.1016/j.vaccine.2022.10.061_b0105
  article-title: Investigating the determinants of vaccine hesitancy within undergraduate students' social sphere
  publication-title: J Public Health
– volume: 9
  start-page: 2649
  year: 2013
  ident: 10.1016/j.vaccine.2022.10.061_b0175
  article-title: Sources of HPV vaccine hesitancy in parents
  publication-title: Human Vaccines Immunother
  doi: 10.4161/hv.26224
– ident: 10.1016/j.vaccine.2022.10.061_b0070
– volume: 397
  start-page: 1023
  year: 2021
  ident: 10.1016/j.vaccine.2022.10.061_b0095
  article-title: Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment
  publication-title: Lancet
  doi: 10.1016/S0140-6736(21)00306-8
– ident: 10.1016/j.vaccine.2022.10.061_b0150
  doi: 10.15585/mmwr.mm7105a3
– volume: 324
  start-page: 931
  year: 2020
  ident: 10.1016/j.vaccine.2022.10.061_b0090
  article-title: Unwavering Regulatory Safeguards for COVID-19 Vaccines
  publication-title: JAMA
  doi: 10.1001/jama.2020.15725
– volume: 10
  year: 2022
  ident: 10.1016/j.vaccine.2022.10.061_b0160
  article-title: Vaccine Hesitancy Among Religious Groups: Reasons Underlying This Phenomenon and Communication Strategies to Rebuild Trust
  publication-title: Front Public Health
  doi: 10.3389/fpubh.2022.824560
– volume: 23
  year: 2020
  ident: 10.1016/j.vaccine.2022.10.061_b0170
  article-title: Attitudes toward vaccinations are becoming more polarized in New Zealand: Findings from a longitudinal survey
  publication-title: EClinicalMedicine
  doi: 10.1016/j.eclinm.2020.100387
– volume: 398
  start-page: 2084
  year: 2021
  ident: 10.1016/j.vaccine.2022.10.061_b0020
  article-title: The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(21)02178-4
– ident: 10.1016/j.vaccine.2022.10.061_b0145
  doi: 10.3389/fpubh.2021.752323
– volume: 24
  year: 2021
  ident: 10.1016/j.vaccine.2022.10.061_b0130
  article-title: Factors associated with COVID-19 vaccine trust and hesitancy among adults with chronic conditions
  publication-title: Prevent Med Rep
– ident: 10.1016/j.vaccine.2022.10.061_b0005
– start-page: 1
  year: 2022
  ident: 10.1016/j.vaccine.2022.10.061_b0135
  article-title: Gender differences in the intention to get vaccinated against COVID-19: a systematic review and meta-analysis
  publication-title: Zeitschrift fur Gesundheitswissenschaften = J Public Health
– volume: 16
  start-page: e0258462
  year: 2021
  ident: 10.1016/j.vaccine.2022.10.061_b0065
  article-title: Individual determinants of COVID-19 vaccine hesitancy
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0258462
– volume: 191
  start-page: 71
  year: 2022
  ident: 10.1016/j.vaccine.2022.10.061_b0085
  article-title: Psychological factors affecting COVID-19 vaccine hesitancy
  publication-title: Ir J Med Sci
  doi: 10.1007/s11845-021-02640-0
– ident: 10.1016/j.vaccine.2022.10.061_b0045
– volume: 194
  start-page: 245
  year: 2021
  ident: 10.1016/j.vaccine.2022.10.061_b0080
  article-title: Vaccine hesitancy in the era of COVID-19
  publication-title: Public Health
  doi: 10.1016/j.puhe.2021.02.025
– ident: 10.1016/j.vaccine.2022.10.061_b0010
  doi: 10.1016/B978-1-4160-3611-1.50005-2
– ident: 10.1016/j.vaccine.2022.10.061_b0035
– volume: 9
  year: 2021
  ident: 10.1016/j.vaccine.2022.10.061_b0185
  article-title: Ethnic differences in SARS-CoV-2 vaccine hesitancy in United Kingdom healthcare workers: Results from the UK-REACH prospective nationwide cohort study
  publication-title: Lancet Reg Health Europe
– volume: 16
  year: 2021
  ident: 10.1016/j.vaccine.2022.10.061_b0110
  article-title: COVID-19 and vaccine hesitancy: A longitudinal study
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0250123
– ident: 10.1016/j.vaccine.2022.10.061_b0015
  doi: 10.1016/j.immuni.2021.07.017
– ident: 10.1016/j.vaccine.2022.10.061_b0100
  doi: 10.1016/j.vaccine.2017.12.043
SSID ssj0005319
Score 2.5339549
Snippet •Two cohorts were surveyed in 2019 and 2022 respectively to evaluate their vaccine confidence.•Vaccine confidence has significantly declined since the onset of...
Highlights•Two cohorts were surveyed in 2019 and 2022 respectively to evaluate their vaccine confidence. •Vaccine confidence has significantly declined since...
Vaccines are among the safest and most effective primary prevention measures. Thanks to the synergistic global efforts of research institutions, pharmaceutical...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 7262
SubjectTerms Allergy and Immunology
Confidence
Coronaviruses
COVID-19
COVID-19 - epidemiology
COVID-19 - prevention & control
COVID-19 infection
COVID-19 vaccines
COVID-19 Vaccines - therapeutic use
Demographics
Demography
Ethics
gender
Health services
Humans
Immunization Programs
Measles
Middle Aged
nationalities and ethnic groups
pandemic
Pandemics
Pandemics - prevention & control
Pharmaceutical industry
Polls & surveys
Public health
Research facilities
Research institutions
Social networks
Statistical analysis
Success
Survey
Surveys
Trends
vaccination
Vaccine confidence
Vaccine hesitancy
Vaccines
SummonAdditionalLinks – databaseName: Science Direct
  dbid: .~1
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBelsLGXsWVfWbuhwehTnTj6tJ_GSFfaQbfC2pI3YckSTVmdMCeFvvRv30mWnWZd6dhj7LvYkk53v7PuA6GPklKqqSgTzqRMGGEuyR3liclY7krrClv675BH38TBKfs64ZMNNG5zYXxYZdT9jU4P2jpeGcbZHM6n0-GPNNjydELAhlEqfcIvY9JL-eDmVpgHDc09PHHiqVdZPMOLwVVh_PE1uImEDHyQlxjdZ5_u4s8_wyhv2aX9Z-hpBJT4c_POz9GGrXroUdNi8rqHHh_Fw_Me2jluylRf7-KTVdZVvYt38PGqgDXw9M58jExI1MUt-wu0d1jjOBIMTrRrupHiosLLyvcJMIBd8ZXPMLnEM4cBWOLx97PDvWSU47n_VH05NZ9eotP9LyfjgyT2YEgMF3KRANzROnMAK7kptSuFZIblrCxsXkgqtHGSG8OL1IWl1Rk1YBJTzbJyJCyz9BXarGaVfYMw0YYS54wk5YgVjmRc58RoAz44c8KUfcTamVcmFij3fTJ-qjYS7ULFYSq_YP4yLFgfDTq2eVOh4yEG0S6ratNPQWEqsCEPMcq_Mdo6bvtajVRNVKruiGYfZR3nmnT_y0O3W8lT3XMAc0rwq1MO__yhuw2KwZ_2FJWdLQNNKHSQivtpPJpOGXjEQPO6EeZuDqmAbQzgHEa9JuYdgS9Mvn6nmp6HAuWhixDjb_9_1Fvoif_lkz5Jto02F7-W9h2gv4V-H7b3b2O8WP0
  priority: 102
  providerName: Elsevier
Title Is vaccine confidence an unexpected victim of the COVID-19 pandemic?
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0264410X22013378
https://www.clinicalkey.es/playcontent/1-s2.0-S0264410X22013378
https://dx.doi.org/10.1016/j.vaccine.2022.10.061
https://www.ncbi.nlm.nih.gov/pubmed/36333226
https://www.proquest.com/docview/2737448058
https://www.proquest.com/docview/2732543106
https://www.proquest.com/docview/3242041486
https://pubmed.ncbi.nlm.nih.gov/PMC9618445
Volume 40
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfYJhASQhA-VhiTkdCeli6xHTt5mka3qQWtVLBNfbNiJxabtrSQdtJe-Ns5J07CgDFe2qrxJXXPvvvd-T4QeicopYryzI-YED4jzPiJoZGvY5aYLDdpnlk_5NGYD0_Yh2k0dQ630oVVNjKxEtTZTFsf-Q6oWQGmRBDFu_Nvvu0aZU9XXQuNFbRmS5fZkC4xFV2IB60ae4CZwXwWBtMug2fnvH-Vant0DSYiIX0b4MXD23TTn9jz9xDKX3TS4RP02IFJvFdz_ym6lxceul-3l7z20IMjd3Duoa1JXaL6ehsfdxlX5TbewpOueDXQPKr9eLhOT_KQd2rjZaqkXdzc7hnaH5XYzQyDQW3qzqQ4LfCysD0DNOBYfGWzTS7xzGAAmXjw6XS074cJnlu39eWZ3n2OTg4PjgdD3_Vj8HXExcIH6KNUbABiRjpTJuOCaZawLM2TVFCutBGR1lEamIrNKqYa1GOgWJyFPGc5fYFWi1mRryNMlKbEGC1IFrLUkDhSCdFKgz3ODNdZD7GGE1K7YuW2Z8aFbKLSzqWbprQMtF8DA3uo35LN62oddxHwhs2ySUUF4SlBn9xFKP5GmJdOBJQylCWRgfwSVJAzmBKAWpSKuIfiltKhnBq9_M9DN5qVKNvndBujh962l0FI2JOftMhny2pMVfQg4LePscg6YGAdw5iX9eJu_0PKYUsDUIdZ31j27QBbpPzmleLsa1WsvOooxKJX__7pr9FDO0-b5EniDbS6-L7M3wDaW6hNtNL_EW5WGxte4wF8XtsbfRyO4f39wXjy-Sc_EljS
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTnxICEH5KgwwEuxp6RLbSZwHNMG6qWVrqVg39c0kTiw2sbSQdqj_FH8j53yVAWO87DX2JXHucvc7-z4AXvmMsYh5seVy37c45doKNHMtJXig40SHSWz2IfsDr3vI34_d8Qr8qHJhTFhlpRNzRR1PlNkj30Qz66MrYbtia_rVMl2jzOlq1UKjEIu9ZPEdXbbsTa-D_H1N6e7OaLtrlV0FLOV6_sxCAx5FQiNQclUc6djzueIBj8MkCH3mRUr7rlJuaOv8ZSPBFCp5O-IidryEJwzvew1WOUNXpgGr73YGw4_LoBKWtxJBx4Zb3LHHy5yhzZP2WajMYTk6pZS2TUiZ51xkDf9Eu78Hbf5iBXfvwp0SvpK3hbzdg5UkbcL1oqHlogk3-uVRfRPWh0VR7MUGGS1zvLINsk6Gy3LZSHO72DkkRUJUE5pHJkInTxMm1e3uQ6eXkXJlBF14XfRCJWFK5qnpUqAQOZMzk99ySiaaIKwl2x-Oeh3LCcjUbJSfHqutB3B4Jbx6CI10kiaPgdBIMaq18mns8FBT4UYBVZESQnDtqbgFvOKEVGV5dNOl44us4uBOZLlMaRhoLiMDW9CuyaZFfZDLCLyKzbJKfkV1LdGCXUbo_40wyUqlk0lHZlTa8sDOQa49pgjuGPNFC0RNWeKqAi_9z0PXKkmU9XOWv2ILXtbDqJbMWVOYJpN5Picvs2B7F88xWN7m6I_jnEeFcNffkHmoRNA1wFWfE_t6gimLfn4kPf6cl0fPexhx98m_X_0F3OyO-vtyvzfYewq3zJpNiikVa9CYfZsnzxBrzqLn5Q9O4NNV65SfICCURA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGEBMSQlC-CgOMBHta2sR2bOcBTWilWhkbldimvJnEscUmlhbSDvVf46_jnK8yYIyXvSa-JM6d735n3wdCLwWlNKU880ImhMcIs15kaehpySKbGZuYzO1D7u3znUP2Lg7jFfSjyYVxYZWNTiwVdTbRbo-8D2ZWgCvhh7Jv67CI8WC4Nf3quQ5S7qS1aadRiciuWXwH9614PRoAr18RMnx7sL3j1R0GPB1yMfPAmKeptACaQp2lNuOCaRaxLDFRIihPtRWh1mHi2_LDU0k1KHw_ZTILuGGGwnOvoeuChoFbYyIWy_ASWjYVAReHeSzw42X2UP-kd5Zod2wO7ikhPRdcxoOL7OKfuPf38M1f7OHwDrpdA1n8ppK8u2jF5B10o2ptueigtb360L6DNsZVeezFJj5YZnsVm3gDj5eFs4HmVrWHiKvUqA7qHLlYnTJhGDePu4cGowLXM8PgzNuqKypOcjzPXb8CDRgan7lMl1M8sRgALt7-cDQaeEGEp27L_PRYb91Hh1fCqQdoNZ_k5hHCJNWUWKsFyQKWWCLDNCI61VJKZrnOuog1nFC6LpTu-nV8UU1E3Imqp6kcA91lYGAX9VqyaVUp5DIC3rBZNWmwoLgV2LLLCMXfCE1Rq59CBaogylcf_RLu-jEBmEepkF0kW8oaYVXI6X9eut5Iomrfs1yUXfSivQ0Kyp06JbmZzMsxZcEFn188xqF6n4FnDmMeVsLd_kPKQZ2AkwCzPif27QBXIP38nfz4c1kovexmxMLH__7052gNNIl6P9rffYJuuim7XFMi19Hq7NvcPAXQOUuflasbo09XrU5-AjXOlxQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Is+vaccine+confidence+an+unexpected+victim+of+the+COVID-19+pandemic%3F&rft.jtitle=Vaccine&rft.au=Siani%2C+Alessandro&rft.au=Tranter%2C+Amy&rft.date=2022-11-28&rft.pub=Elsevier+Limited&rft.issn=0264-410X&rft.eissn=1873-2518&rft.volume=40&rft.issue=50&rft.spage=7262&rft_id=info:doi/10.1016%2Fj.vaccine.2022.10.061&rft.externalDBID=HAS_PDF_LINK
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0264410X%2FS0264410X22X00492%2Fcov150h.gif